Skip to main content
Clinical Trials/NL-OMON27916
NL-OMON27916RecruitingNot Applicable

The effect of the addition of D-cycloserine to exposure sessions in the treatment of patients with obsessive-compulsive disorder. A randomized, placebo-controlled trial.

Meerkanten GGZErmelo0 sites40 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
40

Study Overview

Brief Summary

/A

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Patients with a primary DSM-IV diagnosis of OCD with an age of 18 years and older as established with the Structural Clinical Interview for axis I DSM-IV Disorders (SCID I);
  • 2. Obsessive-compulsive complaints has to be such that exposure in vivo is feasible at the outpatient department, in the clinic or the direct environment;

Exclusion Criteria

  • 1. Addiction to alcohol or drugs or abuse of these compounds;
  • 2. A primary diagnosis of a personality disorder;

Investigators

Sponsor
Meerkanten GGZErmelo

Similar Trials